Targeting calcium regulators as therapy for heart failure: focus on the sarcoplasmic reticulum Ca-ATPase pump

Area of Science:

• Cardiology
• Molecular Biology
• Biochemistry

Background:

• Impaired myocardial calcium (Ca2+) cycling contributes to heart failure (HF) pathogenesis.
• Cardiomyocyte Ca2+ handling is regulated by proteins like the sarcoplasmic reticulum Ca2+ ATPase (SERCA2a) pump.
• Reduced SERCA2a expression/activity is a hallmark of HF, impacting cardiac relaxation and contractility.

Purpose of the Study:

• To review the regulatory mechanisms of the SERCA2a pump.
• To explore potential therapeutic strategies targeting SERCA2a for HF treatment.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of SERCA2a regulatory pathways.

Main Results:

• SERCA2a is crucial for diastolic Ca2+ reuptake into the sarcoplasmic reticulum.
• Decreased SERCA2a function exacerbates HF by impairing relaxation and Ca2+ restoration.
• Various therapeutic approaches targeting SERCA2a are under investigation.

Conclusions:

• Restoring SERCA2a function is a promising therapeutic avenue for heart failure.
• Targeting SERCA2a may improve cardiac contractile function and reverse structural remodeling.
• Ongoing research in preclinical and clinical settings aims to validate SERCA2a-based therapies.